Agenda EURLSSG-Meeting
Friday 13th December 2024, 9:00 - 17:30 h
Welcome:
Literature Overview - Impact of RLS
Wolfgang Oertel, President, Germany
Epidemiology
Chairperson:
Claudia Trenkwalder, Germany
How to assess RLS in large population studies - Expert examination versus classification from questionnaires
Klaus Berger, Germany
Genetics
Chairperson:
Juliane Winkelmann, Germany
Update on the genetics of RLS
Barbara Schormair, Germany
RLS and comorbidity
Chairpersons:
Samson Khachatryan, Armenia
Giorgos Sakkas, Greece
RLS and other sleep disorders among young people of Georgia
Ketevan Mamasakhlisi, Georgia
Restless legs syndrome in traumatic injury
Cristian Falup-Pecurariu, Romania
Prevalance of RLS in patients with multiple sclerosis
Laura L. Triguero, Spain
RLS in stroke - case control study
Iulia Murasan, Romania
RLS as a surrogate of generalized dysautonomia
Olli Polo, Finland
Effect of Restless Leges Syndrome medication on depression - prevalance in patients with RLS: A systemic review and meta-analysis
Yukiyoshi Sumi, Japan
RLS and and peritoneal dialysis - update on a cohort study
Thomas MItterling, Austria
RLS and tghe COVID pandemic
Markku Partinen, Finland
Neurophysiology (and Imaging)
Chairperson:
Federica Proini, Italy
Periodic leg movements (PLM) and large muscle group movements (LMM) during sleep along the lifespan in normal controls
Raffaele Ferri, Italy
EEG for brain connectivity analysis in RLS - preliminary results
Doris Schuller-Götzburg, Austria
Common projects of the EURLSSG
Chairperson:
Wolfgang Oertel, Germany
Preview for Saturday - Summary slides
Case Reports
Chairperson:
Lucia Muntean, Germany
High periodic leg movements persist after weight loss surgery and obstructive sleep apnea improvement
Galia Anguelova, The Netherlands
Restless Back Syndrome
Evi Holzknecht, Austria
Therapy
Chairpersons:
Roselyne Rjisman, The Netherlands
Ambra Stefani, Austria
Physical exercise in restless legs syndrome
Evi Holzknecht, Austria
Treatment response to Tramadol treatment in Japanese patients with restless legs syndrome and its associaated factors
Yuichi Inoue, Japan
Treatment of restless legs syndrome with Sativex (2,7 mg Delta-9-tetra-hydrocannabinol / 2,5 mg cannabidiol)
Laura L. Triguero, Spain
Industrial Session
Chairpersons:
Federica Provini, Italy
Wolfgang Oertel, Germany
Tonic motor activation (TOMAC) - a wearable neurostimulation therapy for Restless Legs Syndrome
Shri Raghunathan, Noctrix, USA
Basic Science
Chairperson:
Barbara Schormair, Germany
Dopamine receptors in restless legs syndrome and augmentation: An update on D3 and D1 receptor hypotheses
Stefan Clemens, USA
EARLS
Chairpersons:
Katharina Glanz, Germany
Stefan Clemens, USA
Making the invisible visible - 15 years EARLS RLS Patient Advocacy
Katharina Glanz, EARLS President, Germany
How far have we succeded in our ambition to make primary care doctors updated on basic facts on RLS treatment
Sören Berg, President of RLS-Förbundet, Sweden
Agenda EURLSSG-Meeting
Saturday 14th December 2024, 9:00 - 13:30 h
Welcome
Wolfgang Oertel, President, Germany
Common Projects of the EURLSSG
Chairpersons:
Federica Provini, Italy
Wolfgang Oertel, Germany
DATA BASE - RLS experts - physicians
ANgelica Montini, Barbara Schormair, Wolfgang Oertel, Klaus Berger, Federica Provini and the EURLSSG
DATA BASE - European RLS Patient-Registry
Wolfgang Oertel, Joke Jaarsma
Chairpersons:
Samson Khachatryan, Armenia
Giorgos Sakkas, Greece
USA-RLS Guidelines - versus European views
Shall EURLSSG endorse the USA-Recommendations?
Ambra Stefani and Samson Khachatryan
Task Force European Grant application
Giorgos Sakkas and Stefan Clemens
Task Force Website Content and Support
Burkhard Panier and Wolfgang Oertel
Augmentation Rating Scale - Validation of translations?
Development of new rating scales / questionnaires (Comorbidity)?
Educational material - for and together with EAN and ESRS?
Others